About us
We are advancing particle detection through our innovative technologies. Specializing in Circulating Tumor Cells (CTC) detection, our solutions are designed to enhance the accuracy and efficiency of cancer treatment decisions, particularly in breast cancer care. By integrating advanced microfluidics, optoelectronics, and machine learning, we are pioneering a new era of personalized medicine that offers clinicians real time data to guide therapy choices.
Get in touch
© 2026 The Ledger. All rights reserved.